A Guide to Treatment of Sarcoidosis

Author(s): Ilias C. Papanikolaou, Hidenobu Shigemitsu, Om P. Sharma

Journal Name: Current Drug Therapy

Volume 5 , Issue 2 , 2010

Become EABM
Become Reviewer
Call for Editor


Not all sarcoidosis patients need treatment. In about 40% of cases, disease will subside spontaneously. For the rest who need to be treated, older drugs like corticosteroids, methotrexate and hydroxychloroquine, as well as the more recent anti-TNF agents, will be effective in suppressing granulomatous inflammation in every organ involved in about 30% of cases. In 20% of the patients, disease will relapse upon discontinuation or tapering of treatment, and in 10% will progress (these two categories constituting chronic disease). In these cases, reinstitution of the same or alternative medication or a combination regimen is warranted. Drugs side-effects and patients comorbidities should be taken in consideration during the selection of the appropriate regimen.

Keywords: Sarcoidosis, treatment, corticosteroids, methotrexate, hydroxychloroquine, infliximab

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2010
Page: [122 - 131]
Pages: 10
DOI: 10.2174/157488510791065102
Price: $65

Article Metrics

PDF: 3